| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000016851 |
| Receipt No. | R000019004 |
| Official scientific title of the study | Exploratory Research for the induction of natural killer cell propagated from G-CSF mobilized hematopoietic stem cells that were collected by apheresis method |
| Date of disclosure of the study information | 2015/03/20 |
| Last modified on | 2018/06/12 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Exploratory Research for the induction of natural killer cell propagated from G-CSF mobilized hematopoietic stem cells that were collected by apheresis method | |
| Title of the study (Brief title) | Exploratory Research for the induction of NK cell propagated from hematopoietic stem cells in peripheral blood | |
| Region |
|
|
| Condition | |||
| Condition | hapatocellular carcinoma | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | We evaluate the induction efficiency of natural killer cells from G-CSF mobilized hematopoietic stem cells collected by apheresis in peripheral blood. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The number of NK cell from hematopoietic stem cell |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | G-CSF and apheresis | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (a) Healthy volunteer who agreed the purpose of this research
(b) more than 20 years old or less than 70years old (c) The person who can come to this hospital continuously as per the time interval mentioned in the protocol (d) Informed consent must be taken. |
|||
| Key exclusion criteria | (a) The person who suffered allergic reaction from the material of GRAN or other G-CSF
(b) The level of blood test as mentioned below. Hgb: less than 12 (female), or 13 (male) WBC: less than 3000 /mm^3 Neutrophil:less than 1500 /mm^3 Platelet: less than 100 x 10^3 /mm^3 Biochemical test as mentioned below. AST, ALT, T-Bil, ALP, g-GTP, LDH, Total protein, Alb, T-chol, BUN, Cr, Na, K, Cl, Uric acid and CRP: more than standard level (c) The people who can stop drinking during injection of G-CSF (d) The breast feeding mother or pregnantlady (e) The doctor's disagrement for the registration due to some underlying medical conditon |
|||
| Target sample size | 3 | |||
| Research contact person | |
| Name of lead principal investigator | Hideki Ohdan |
| Organization | Hirohshima university |
| Division name | Department of Gastroenterological and Transplant Surgery |
| Address | 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan |
| TEL | 082-257-5220 |
| hohdan@hiroshima-u.ac.jp | |
| Public contact | |
| Name of contact person | Yuka Tanaka |
| Organization | Hirohshima university |
| Division name | Department of Gastroenterological and Transplant Surgery |
| Address | 1-2-3, Kasumi, Minami-ku, Hiroshima, Japan |
| TEL | 082-257-5222 |
| Homepage URL | |
| yukasan@hiroshima-u.ac.jp | |
| Sponsor | |
| Institute | Hiroshima university |
| Institute | |
| Department | |
| Funding Source | |
| Organization | This study was funded by a Research on Hepatitis and BSE grant from the Japanese Ministry of Health, Labor and Welfare. |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019004 |